NCT05581693View on ClinicalTrials.gov

A Bioequivalence Study of L04TD2 Compared to Administration of L04RD1 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

September 30, 2022

Primary Completion Date

November 1, 2022

Study Completion Date

November 29, 2022

Conditions

Healthy

Interventions

DRUG

L04RD1

1 tablet of L04RD1

DRUG

L04TD2

1 tablet of L04TD2

DRUG

L04TD2

1 tablet of L04TD2

DRUG

L04RD1

1 tablet of L04RD1

Trial Locations (1)

08756

Jaewoo Kim, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celltrion

INDUSTRY